Literature DB >> 12722159

Cryptolepine hydrochloride: a potent antimycobacterial alkaloid derived from Cryptolepis sanguinolenta.

Simon Gibbons1, Fatemeh Fallah, Colin W Wright.   

Abstract

The activity of cryptolepine hydrochloride, a salt of the main indoloquinoline alkaloid from the West African medicinal plant Cryptolepis sanguinolenta, was assessed against the fast growing mycobacterial species Mycobacterium fortuitum, which has recently been shown to be of use in the evaluation of antitubercular drugs. The low minimum inhibitory concentration (MIC) of this compound (16 microg/mL) prompted further evaluation against other fast growing mycobacteria namely, M. phlei, M. aurum, M. smegmatis, M. bovis BCG and M. abcessus and the MICs ranged over 2-32 microg/mL for these species. The strong activity of this agent, the need for new antibiotics with activity against Mycobacterium tuberculosis, coupled with the ethnobotanical use of C. sanguinolenta extracts to treat infections, highlight the potential of the cryptolepine template for development of antimycobacterial agents. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12722159     DOI: 10.1002/ptr.1284

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  7 in total

1.  Design and in vitro haemolytic evaluation of cryptolepine hydrochloride-loaded gelatine nanoparticles as a novel approach for the treatment of malaria.

Authors:  Noble Kuntworbe; Raida Al-Kassas
Journal:  AAPS PharmSciTech       Date:  2012-04-05       Impact factor: 3.246

2.  Recent Advances in the Chemistry and Pharmacology of Cryptolepine.

Authors:  Steven D Shnyder; Colin W Wright
Journal:  Prog Chem Org Nat Prod       Date:  2021

3.  Antibacterial activities of naturally occurring compounds against Mycobacterium avium subsp. paratuberculosis.

Authors:  Stella Y Y Wong; Irene R Grant; Mendel Friedman; Christopher T Elliott; Chen Situ
Journal:  Appl Environ Microbiol       Date:  2008-08-01       Impact factor: 4.792

Review 4.  Indolo[3,2-b]quinolines: synthesis, biological evaluation and structure activity-relationships.

Authors:  Eyunni V K Suresh Kumar; Jagan R Etukala; Seth Y Ablordeppey
Journal:  Mini Rev Med Chem       Date:  2008-06       Impact factor: 3.862

5.  Cryptolepine inhibits melanoma cell growth through coordinated changes in mitochondrial biogenesis, dynamics and metabolic tumor suppressor AMPKα1/2-LKB1.

Authors:  Harish C Pal; Ram Prasad; Santosh K Katiyar
Journal:  Sci Rep       Date:  2017-05-04       Impact factor: 4.379

6.  Cryptolepine, a Plant Alkaloid, Inhibits the Growth of Non-Melanoma Skin Cancer Cells through Inhibition of Topoisomerase and Induction of DNA Damage.

Authors:  Harish C Pal; Santosh K Katiyar
Journal:  Molecules       Date:  2016-12-21       Impact factor: 4.411

Review 7.  Unravelling the pharmacological properties of cryptolepine and its derivatives: a mini-review insight.

Authors:  Champa Keeya Tudu; Anustup Bandyopadhyay; Manoj Kumar; Tuyelee Das; Samapika Nandy; Mimosa Ghorai; Abilash Valsala Gopalakrishnan; Jarosław Proćków; Abhijit Dey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-10-17       Impact factor: 3.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.